Rathbones Group PLC Mesoblast LTD Transaction History

Rathbones Group PLC

  • $19 Billion
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
BUY
$8.26 - $11.4 $201,833 - $278,559
24,435 New
24,435 $202,000

Others Institutions Holding MESO

# of Institutions
3
Shares Held
151K
Call Options Held
0
Put Options Held
0
View Full List

About MESOBLAST LTD

MESO Quotes by TradingView
  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $2.51B
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track This Portfolio

Track Rathbones Group PLC Portfolio

Follow Rathbones Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rathbones Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Rathbones Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email